Novo Nordisk says Wegovy shows greater weight loss than Eli Lilly's rival pill
Culture Index
Score Breakdown
Relevance
3/25
Freshness
25/25
Authority
18/20
Brand Signal
8/15
Depth
2/15
5-Axis Cultural Radar
A cross-trial comparison shows Novo's oral semaglutide produced three percentage points more weight loss and fewer dropouts due to side effects
%20(1).png)

